Search results for:

mitoMYcin ophthalmic

mitoMYcin ophthalmic
Brand names: Mitosol
Form Strength
KIT, OPHTHALMIC 0.2 mg
Display Antineoplastic Agents Class: 100000
High Alert Drug : Policy
Medication comments:

High Alert Drug: Chemotherapeutic Agents - Parenteral
 • Stored separately in pharmacy.
 • Pharmacist reviews literature in order to to verify calculations and dose prescribed.
 • Two pharmacists independently verify preparation.
 • No telephone orders. Pre-printed order sheet available.
 • Chemo is administered by specially trained RNs.
 • 2 RNs independently verify pump settings and drug on continuous infusions prior to administration.
 • IV sites are assessed every 2 hours.
 • Drugs are transported in plastic bags/designated transport containers labeled with sticker indicating CHEMOTHERAPY DRUG.
Per policy, these hazardous drugs have special waste requirements. 
Generic (Brand) Waste Requirements
mitoMYcin ophthalmic (Mitosol) If > 3% by weight of drug remains ⇒  BLACK BUCKET 
Trace amounts/uncontaminated PPE ⇒  YELLOW BUCKET 
USP <800> Hazardous Drug Assessment of Risk (AOR)
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense] NIOSH Group
mitoMYcin (Mitosol) OPTH [UD ⇒ UD] Antineoplastic
Pharmacy:
Receiving /
Storage /
Preparation

Exposure Risk:
minimal
 • Handling/preparation PPE Requirements: n/a
• Receiving from Distributor: Designated area/  CX gloves 
• Pharmacy Storage Area: Chemo
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location: n/a
• Omnicell Load: No
Transport • Transport (dose is placed inside a plastic sealable bag): Transport container, single  CX gloves 
Nursing:
Storage /
Admin.

Exposure Risk:
low
 • Handling/administration PPE Requirements: Double  CX gloves  and  gown 
• Storage of Finished dose in Nursing Area/Procedural Area: Picked up from Pharmacy
• Signage on Patient Door Required: Yes
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration:
Disposal /
Spills		 • Disposal of Drug Waste: Full-  black bin , trace-  yellow bin 
• Disposol of Used PPE:  yellow bin 
• Spill management: Manage like antineoplastic agents
Last updated: Jun. 12, 2024
  • Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug / Assessment of Risk
  • Hazardous Waste BLACK BUCKET/YELLOW BUCKET
  • Chemotherapy
  • Look-Alike/Sound-Alike mitoMYcin confused with mitoXANTRONE
Lexicomp Online Search

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.
Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved